Growing community of inventors

Boston, MA, United States of America

Navreet Dhindsa

Average Co-Inventor Count = 7.00

ph-index = 6

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 71

Navreet Dhindsa ↔ Victor Mandla Moyo (8 patents)Navreet Dhindsa ↔ Clet Niyikiza (8 patents)Navreet Dhindsa ↔ Jonathan Basil Fitzgerald (8 patents)Navreet Dhindsa ↔ Eliel Bayever (8 patents)Navreet Dhindsa ↔ Peter Laivins (8 patents)Navreet Dhindsa ↔ Jaeyeon Kim (8 patents)Navreet DhindsaNavreet Dhindsa (8 patents)Victor Mandla MoyoVictor Mandla Moyo (43 patents)Clet NiyikizaClet Niyikiza (37 patents)Jonathan Basil FitzgeraldJonathan Basil Fitzgerald (19 patents)Eliel BayeverEliel Bayever (9 patents)Peter LaivinsPeter Laivins (8 patents)Jaeyeon KimJaeyeon Kim (8 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Merrimack Pharmaceuticals, Inc. (4 from 52 patents)

2. Ipsen Biopharm Limited (4 from 41 patents)


8 patents:

1. 12364691 - Methods for treating pancreatic cancer using combination therapies

2. 11369597 - Methods for treating pancreatic cancer using combination therapies

3. 10980795 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

4. 9717724 - Methods for treating pancreatic cancer using combination therapies

5. 9492442 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

6. 9452162 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

7. 9364473 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

8. 9339497 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…